Development in PaCO2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula—post-hoc analysis from a randomised controlled trial
Introduction Persistent hypercapnic failure in chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. Long-term home non-invasive ventilation is recommended for patients with PaCO2 >7.0 kPa. Domiciliary high-flow nasal cannula (HFNC) reduces PaCO2 in short-term studie...
Saved in:
| Main Authors: | Line Hust Storgaard, Hans-Ulrich Hockey, Ulla Møller Weinreich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/7/1/e000712.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-flow nasal cannula therapy for initial oxygen administration in acute hypercapnic respiratory failure: study protocol of randomised controlled unblinded trial
by: Bronagh Blackwood, et al.
Published: (2021-11-01) -
Domiciliary high-flow treatment in patients with COPD and chronic hypoxic failure: In whom can we reduce exacerbations and hospitalizations?
by: Ulla Møller Weinreich
Published: (2019-01-01) -
Plasma Orexin-A Levels in COPD Patients with Hypercapnic Respiratory Failure
by: Lin-Yun Zhu, et al.
Published: (2011-01-01) -
High-flow nasal cannula versus non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: a retrospective study
by: Nicolás Colaianni-Alfonso, et al.
Published: (2025-06-01) -
A scoping review protocol on brain PaCO2 levels at altitude.
by: Hanna Tang, et al.
Published: (2025-01-01)